We bring you an important notice from the Italian Medicines Agency concerning Darunavir and Cobicistat: AIFA has released new information on an increased risk of HIV treatment failure and of vertical (mother to child) HIV transmission due to low exposure to Darunavir and Cobicistat during the 2nd and 3rd trimester of pregnancy.
Read here for further information.